Daniel Laury

CEO & Chief Product Officer at udelv

📍 San Francisco, California, United States🔄 Updated September 2026💼 7 investments📅 12 years investing🗓 Last invested Aug 2018𝕏 @upgrade_to_unlock
Operator-angel🌍 United States
7
Total investments
2
Early stage
2
Mid stage
0
Late stage
12y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Aug 2018
On July 1, 2024, IBM acquired StreamSets, a real-time data integration company specializing in streaming structured, unstructured and semistructured data across hybrid multicloud environments. Acquired from Software AG along with webMethods, this strategic acquisition expands IBM’s already robust data integration capabilities, helping to solidify our position as a leader in the data integration market and enhancing IBM Data Fabric’s delivery of secure, high-quality data for artificial intelligence (AI). Existing StreamSets clients continue to receive the same high level of support and service they have come to expect. Moreover, this acquisition brings increased investment to extend connectivity and CDC support, integrate with data lineage and data observability, and focus on end-to-end data pipeline orchestration.
Investor
Dec 2016
GridRaster is a pioneering technology company transforming how industrial sectors leverage spatial computing and AI for automation, robotics, and digital twins. We recognized early on the transformative potential of XR, AI, and cloud technologies to enhance efficiency and productivity across the entire product life cycle—from design and assembly to manufacturing, training, and maintenance operations. Utilizing distributed edge computing, low-latency remote rendering, and 3D AI-driven spatial mapping, GridRasters cloud-based XR platform was developed in collaboration with large enterprise customers in the aerospace, automotive, and telecommunications industries. Our clientele includes the US Air Force, US Space Force, US Army, leading aerospace and space companies, and top telecommunications firms. GridRaster currently offers the following products: GridRaster Digital Twin Solution: A 3D scanning solution utilizing commercial off-the-shelf XR devices (such as HL2, iOS Tablet, iPhone Pro) to create 3D digital twins ten times faster and at a tenth of the cost, with millimeter accuracy. GridRaster Workspace: Provides an ultra-realistic virtual environment for multi-user real-time collaboration and dynamic XR simulations, powered by GridRasters high-fidelity, low-latency XR streaming capability. GridRaster AI-enabled XR Platform: A revolutionary product leveraging Spatial AI for advanced object recognition to identify and track objects in real-time. It enables millimeter-precision overlay of virtual assets on physical assets without markers, supporting use-cases like holographic quality inspection, automated defect/anomaly detection, and contextual overlay of work instructions in congested spaces. For more information, visit our website: GridRaster
Investor
Mar 2016
Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.
Investor and Board Observer
Aug 2015
Surkus is a product discovery platform where DTC businesses can source feedback and content creation from consumers by offering free or heavily discounted products.
Investor
Jun 2014
Sisense is an API-first analytics platform that modernizes businesses by seamlessly embedding in-context analytics within applications, leading to action-oriented insights that enhance decision intelligence. Established in Israel in 2004, Sisense currently has locations in New York, London, and Tel Aviv, and has served over 2000 customers. To learn more, visit www.sisense.com.
Experience · 12 entries
All (12)
Investments (7)
Founder (3)
Board (1)
2018
Investor
Aug 2018
On July 1, 2024, IBM acquired StreamSets, a real-time data integration company specializing in streaming structured, unstructured and semistructured data across hybrid multicloud environments. Acquired from Software AG along with webMethods, this strategic acquisition expands IBM’s already robust data integration capabilities, helping to solidify our position as a leader in the data integration market and enhancing IBM Data Fabric’s delivery of secure, high-quality data for artificial intelligence (AI). Existing StreamSets clients continue to receive the same high level of support and service they have come to expect. Moreover, this acquisition brings increased investment to extend connectivity and CDC support, integrate with data lineage and data observability, and focus on end-to-end data pipeline orchestration.
2016
Investor
Dec 2016
GridRaster is a pioneering technology company transforming how industrial sectors leverage spatial computing and AI for automation, robotics, and digital twins. We recognized early on the transformative potential of XR, AI, and cloud technologies to enhance efficiency and productivity across the entire product life cycle—from design and assembly to manufacturing, training, and maintenance operations. Utilizing distributed edge computing, low-latency remote rendering, and 3D AI-driven spatial mapping, GridRasters cloud-based XR platform was developed in collaboration with large enterprise customers in the aerospace, automotive, and telecommunications industries. Our clientele includes the US Air Force, US Space Force, US Army, leading aerospace and space companies, and top telecommunications firms. GridRaster currently offers the following products: GridRaster Digital Twin Solution: A 3D scanning solution utilizing commercial off-the-shelf XR devices (such as HL2, iOS Tablet, iPhone Pro) to create 3D digital twins ten times faster and at a tenth of the cost, with millimeter accuracy. GridRaster Workspace: Provides an ultra-realistic virtual environment for multi-user real-time collaboration and dynamic XR simulations, powered by GridRasters high-fidelity, low-latency XR streaming capability. GridRaster AI-enabled XR Platform: A revolutionary product leveraging Spatial AI for advanced object recognition to identify and track objects in real-time. It enables millimeter-precision overlay of virtual assets on physical assets without markers, supporting use-cases like holographic quality inspection, automated defect/anomaly detection, and contextual overlay of work instructions in congested spaces. For more information, visit our website: GridRaster
Investor
Mar 2016
Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.
2015
Investor and Board Observer
Aug 2015
Surkus is a product discovery platform where DTC businesses can source feedback and content creation from consumers by offering free or heavily discounted products.
Managing Director
May 2015
Venture Fund and Innovation Accelerator for Exponential Technologies. We provide seed, growth capital and services to life-transforming businesses with outsized potential
Show all 12 entries ↓
Investment activity
2014–2018 · 7 investments
20143201512016220181
Recent (last 2 years)Earlier